HSBC Holdings’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$286M Sell
641,961
-202,714
-24% -$90.2M 0.17% 100
2025
Q1
$409M Sell
844,675
-29,080
-3% -$14.1M 0.25% 60
2024
Q4
$352M Buy
873,755
+18,739
+2% +$7.54M 0.2% 75
2024
Q3
$397M Sell
855,016
-49,726
-5% -$23.1M 0.23% 65
2024
Q2
$425M Buy
904,742
+98,800
+12% +$46.4M 0.26% 65
2024
Q1
$337M Buy
805,942
+191,273
+31% +$79.9M 0.23% 77
2023
Q4
$250M Buy
614,669
+53,862
+10% +$21.9M 0.22% 76
2023
Q3
$195M Sell
560,807
-121,386
-18% -$42.2M 0.2% 79
2023
Q2
$240M Buy
682,193
+118,878
+21% +$41.8M 0.24% 70
2023
Q1
$177M Buy
563,315
+74,725
+15% +$23.5M 0.21% 83
2022
Q4
$141M Buy
488,590
+176,722
+57% +$50.9M 0.16% 114
2022
Q3
$90.9M Sell
311,868
-18,892
-6% -$5.51M 0.15% 106
2022
Q2
$93.2M Sell
330,760
-17,468
-5% -$4.92M 0.13% 120
2022
Q1
$90.5M Sell
348,228
-30,985
-8% -$8.05M 0.11% 140
2021
Q4
$83.6M Sell
379,213
-21,846
-5% -$4.81M 0.08% 199
2021
Q3
$72.9M Buy
401,059
+42,914
+12% +$7.8M 0.07% 205
2021
Q2
$71.6M Buy
358,145
+56,678
+19% +$11.3M 0.08% 218
2021
Q1
$64.7M Sell
301,467
-58,268
-16% -$12.5M 0.08% 227
2020
Q4
$84.1M Buy
359,735
+61,071
+20% +$14.3M 0.11% 155
2020
Q3
$81.3M Buy
298,664
+74,598
+33% +$20.3M 0.13% 124
2020
Q2
$65M Sell
224,066
-2,983
-1% -$866K 0.12% 127
2020
Q1
$53.5M Buy
227,049
+16,710
+8% +$3.94M 0.12% 143
2019
Q4
$47M Sell
210,339
-64,040
-23% -$14.3M 0.08% 206
2019
Q3
$46.5M Buy
274,379
+22,616
+9% +$3.83M 0.09% 189
2019
Q2
$46.2M Buy
251,763
+93,849
+59% +$17.2M 0.09% 190
2019
Q1
$29M Buy
157,914
+12,924
+9% +$2.38M 0.05% 284
2018
Q4
$23.8M Sell
144,990
-66,863
-32% -$11M 0.04% 300
2018
Q3
$40.8M Buy
211,853
+17,772
+9% +$3.42M 0.07% 233
2018
Q2
$33M Sell
194,081
-86,920
-31% -$14.8M 0.06% 266
2018
Q1
$45.8M Buy
281,001
+29,050
+12% +$4.73M 0.07% 245
2017
Q4
$37.8M Sell
251,951
-61,476
-20% -$9.21M 0.05% 323
2017
Q3
$47.7M Buy
313,427
+57,668
+23% +$8.77M 0.08% 209
2017
Q2
$33M Buy
255,759
+110,408
+76% +$14.2M 0.06% 274
2017
Q1
$15.9M Buy
145,351
+18,067
+14% +$1.98M 0.03% 434
2016
Q4
$9.38M Buy
127,284
+18,676
+17% +$1.38M 0.02% 556
2016
Q3
$9.47M Buy
108,608
+4,288
+4% +$374K 0.02% 536
2016
Q2
$8.97M Sell
104,320
-20,448
-16% -$1.76M 0.02% 538
2016
Q1
$9.92M Buy
124,768
+8,888
+8% +$707K 0.03% 521
2015
Q4
$14.6M Sell
115,880
-47,648
-29% -$6M 0.04% 440
2015
Q3
$17M Sell
163,528
-297,223
-65% -$31M 0.04% 408
2015
Q2
$56.9M Buy
460,751
+189,921
+70% +$23.4M 0.12% 180
2015
Q1
$32M Buy
270,830
+22,799
+9% +$2.69M 0.06% 287
2014
Q4
$29.5M Sell
248,031
-50,455
-17% -$6M 0.06% 277
2014
Q3
$33.6M Buy
298,486
+100,336
+51% +$11.3M 0.07% 243
2014
Q2
$18.7M Buy
198,150
+15,559
+9% +$1.47M 0.04% 381
2014
Q1
$12.8M Buy
182,591
+32,893
+22% +$2.31M 0.03% 431
2013
Q4
$11.1M Buy
149,698
+29,747
+25% +$2.21M 0.03% 457
2013
Q3
$9.1M Buy
119,951
+114,306
+2,025% +$8.67M 0.02% 513
2013
Q2
$451K Buy
+5,645
New +$451K ﹤0.01% 1036